T 0529/94 (Blood substitutes/D.LONG) du 09.10.1997
- Identifiant européen de la jurisprudence
- ECLI:EP:BA:1997:T052994.19971009
- Date de la décision
- 9 octobre 1997
- Numéro de l'affaire
- T 0529/94
- Requête en révision de
- -
- Numéro de la demande
- 87300248.9
- Classe de la CIB
- A61K 9/10
- Langue de la procédure
- Anglais
- Distribution
- Distribuées aux présidents des chambres de recours (C)
- Téléchargement
- Décision en anglais
- Versions JO
- Aucun lien JO trouvé
- Autres décisions pour cet affaire
- -
- Résumés pour cette décision
- -
- Titre de la demande
- Fluorocarbon blood substitutes
- Nom du demandeur
- ALLIANCE PHARMACEUTICAL CORP.
- Nom de l'opposant
- -
- Chambre
- 3.3.02
- Sommaire
- -
- Dispositions juridiques pertinentes
- European Patent Convention Art 123(2) 1973European Patent Convention R 67 1973European Patent Convention R 86(3) 1973
- Mots-clés
- Amendments (yes) - late submitted amendments disclosed in the filed application
Procedural violation (no) - sufficient reasons to exercise the discretion provided for by Rule 86(3)
Second oral proceedings correctly denied - Exergue
- -
- Affaires citées
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
The case is remitted to the department of first instance with the order to grant a patent with the following claims and description:
claims 1 to 23 for all the contracting states except AT and ES, filed on 14 June 1993, and claims 1 to 23 for the contracting states AT and ES, filed on 14 June 1993, with claims 3 and 4 of both sets as amended with the appellants' letter of 11 April 1997 and resubmitted in their entirety by telefax of 15. September 1997; description: pages 1 to 16 as set out in the communication under Rule 51(4) EPC dated 8 June 1993.
2. The request for reimbursement of the appeal fee is refused.